Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells
- 1 July 1997
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 149 (1), 19-25
- https://doi.org/10.1016/s0022-510x(97)05376-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Muscle involvement in human immunodeficiency virus-infected patients is associated with marked selenium deficiencyMuscle & Nerve, 1997
- Effect of zidovudine (AZT) on the structure and function of rat skeletal muscleCanadian Journal of Physiology and Pharmacology, 1996
- Myopathy and HIV infectionCurrent Opinion in Rheumatology, 1995
- Satellite Cell Myogenesis Is Highly Stimulated by the Kinase Inhibitor Iso-H7: Comparison with HA1004 and Staurosporine EffectsBiochemical and Biophysical Research Communications, 1993
- Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudineMuscle & Nerve, 1992
- Massive conversion of guanosine to 8-hydroxy-guanosine in mouse liver mitochondrial DNA by administration of azidothymidineBiochemical and Biophysical Research Communications, 1991
- Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complexThe Lancet, 1990
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990
- Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related DideoxynucleosidesNew England Journal of Medicine, 1989
- Human myotube differentiation in vitro in different culture conditionsBiology of the Cell, 1986